A Study of Modified mRNA Vaccines in Healthy Adults
Conditions: SARS-CoV-2; Seasonal Influenza; Respiratory Syncytial Virus; Cytomegalovirus Interventions: Biological: mRNA-1273; Biological: mRNA-1010; Biological: mRNA-1345; Biological: FLUAD®; Biological: mRNA-1647 Sponsor: ModernaTX, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials